Literature DB >> 9488396

Down regulation of macrophage activation in Brugia pahangi-infected jirds (Meriones unguiculatus).

C Nasarre1, J L Krahenbuhl, T R Klei.   

Abstract

The macrophage is a major component of the inflammatory response induced by lymphatic tissue-dwelling filariae. Intraperitoneal (i.p.) infections with Brugia pahangi in Mongolian gerbils, or jirds (Meriones unguiculatus), induce a peritoneal inflammatory response characterized by accumulation of numerous macrophages and fewer eosinophils. This inflammatory response is associated with the release of microfilariae by female worms. The aim of this study was to investigate the activation state of the peritoneal macrophages during the course of i.p. infections with either male or female worms. Activation was determined by a toxoplasmacidal assay and assays which measured the production of tumor necrosis factor (TNF)-like activity and nitric oxide (NO) production. The development of these assays with jirds was initially conducted in parallel with the mouse system, which served as a positive control. Jird macrophages became activated to kill Toxoplasma gondii by in vivo immunization with Mycobacterium bovis BCG in a pattern similar to that of mouse macrophages. However, unlike the mouse system, supernatants from purified protein derivative- or concanavalin A-stimulated jird splenocytes plus lipopolysaccharide failed to activate jird macrophages in vitro or induce NO production. These results indicate that factors involved in jird macrophage activation may differ from those demonstrated in the mouse system and other systems. i.p. infections of 15 days in duration with either male or female worms induced macrophage activation as measured by Toxoplasma killing and TNF production. These responses decreased as the infection progressed to the chronic period on a time course that parallels the down regulation of experimental B. pahangi granulomas. There was no evidence of NO production by activated jird macrophages. These data indicate that macrophage function is down modulated during filarial infection and suggest that mechanisms involved in macrophage deactivation are related to those that induce down modulation of the systemic granulomatous inflammatory response in the jird. This response is not dependent on the microfilarial stage of the parasite and is also independent of mechanisms which induce peritoneal accumulations of macrophages.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9488396      PMCID: PMC108016          DOI: 10.1128/IAI.66.3.1063-1069.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  59 in total

1.  Brugia pahangi: differential induction and regulation of jird inflammatory responses by life-cycle stages.

Authors:  C Nasarre; S U Coleman; U R Rao; T R Klei
Journal:  Exp Parasitol       Date:  1997-09       Impact factor: 2.011

Review 2.  Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection.

Authors:  N E Reiner
Journal:  Immunol Today       Date:  1994-08

3.  Macrophages as effector cells of protective immunity in murine schistosomiasis.

Authors:  S L James; J K Lazdins; M S Meltzer; A Sher
Journal:  Cell Immunol       Date:  1982-03-01       Impact factor: 4.868

4.  Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.

Authors:  S J Green; R M Crawford; J T Hockmeyer; M S Meltzer; C A Nacy
Journal:  J Immunol       Date:  1990-12-15       Impact factor: 5.422

Review 5.  Human monocytes/macrophages: NO or no NO?

Authors:  M Denis
Journal:  J Leukoc Biol       Date:  1994-05       Impact factor: 4.962

6.  Macrophage-mediated tumor cell killing: regulation of expression of cytolytic activity by prostaglandin E.

Authors:  S M Taffet; S W Russell
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

7.  Conditions for bacille Calmette-Guérin-induced resistance to infection with Schistosoma mansoni in mice.

Authors:  R H Civil; K S Warren; A A Mahmoud
Journal:  J Infect Dis       Date:  1978-05       Impact factor: 5.226

8.  In vitro killing of schistosomula of Schistosoma mansoni by BCG and C. parvum-activated macrophages.

Authors:  A A Mahmoud; P A Peters; R H Civil; J S Remington
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

9.  Interleukin-4 inhibits human macrophage activation by tumor necrosis factor, granulocyte-monocyte colony-stimulating factor, and interleukin-3 for antileishmanial activity and oxidative burst capacity.

Authors:  J L Ho; S H He; M J Rios; E A Wick
Journal:  J Infect Dis       Date:  1992-02       Impact factor: 5.226

10.  Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria.

Authors:  G S Douvas; D L Looker; A E Vatter; A J Crowle
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

View more
  4 in total

1.  Recombinant Brugia malayi pepsin inhibitor (rBm33) induced monocyte function and absence of apoptotic cell death: an in vitro study.

Authors:  Kirthika Sreenivas; Kamalakannan Vijayan; Subash Babu; Rangarajan Badri Narayanan
Journal:  Microb Pathog       Date:  2012-03-30       Impact factor: 3.738

2.  Modulation of B-cell proliferative response by a soluble extract of Nippostrongylus brasiliensis.

Authors:  H N Ehigiator; A W Stadnyk; T D Lee
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

3.  Removal of Wolbachia from Brugia pahangi is closely linked to worm death and fecundity but does not result in altered lymphatic lesion formation in Mongolian gerbils (Meriones unguiculatus).

Authors:  Sharon R Chirgwin; Sharon U Coleman; Kristina H Porthouse; Jena M Nowling; George A Punkosdy; Thomas R Klei
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

4.  Infective Larvae of Brugia malayi Induce Polarization of Host Macrophages that Helps in Immune Evasion.

Authors:  Aditi Sharma; Pankaj Sharma; Laxmi Ganga; Neha Satoeya; Shikha Mishra; Achchhe Lal Vishwakarma; Mrigank Srivastava
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.